April 2024 MHRA Safety Communications
The MHRA has published a comprehensive summary of letters and safety notifications issued to healthcare professionals during April 2024. This update covers recent medicine recalls and device safety information relevant to clinical practice across all care settings.
Key Points
This monthly summary consolidates important safety communications that may affect your prescribing, dispensing, and clinical decision-making. The MHRA regularly issues alerts to ensure healthcare professionals remain informed of emerging safety concerns, product recalls, and regulatory actions.
What You Need to Know
- Multiple medicines and medical devices were subject to safety communications in April 2024
- Two new Device Safety Information pages have been published
- All communications are relevant to primary and secondary care settings
- Timely review of these alerts helps ensure patient safety and regulatory compliance
Recommended Action
Review the full MHRA alert to identify any medicines or devices used in your setting. If you manage stock, prescribe, or administer any affected products, ensure your team is briefed on the specific safety concerns and any required actions (such as stock checks, patient notifications, or alternative prescribing).